OCGN Jan 2024 7.500 call
| Previous close | 0.0800 |
| Open | 0.0700 |
| Bid | 0.0800 |
| Ask | 0.1400 |
| Strike | 7.50 |
| Expiry date | 2024-01-19 |
| Day's range | 0.0700 - 0.0900 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.28k |
- GlobeNewswire
Ocugen, Inc. to Present at 2023 BIO CEO & Investor Conference
MALVERN, Pa., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that Dr. Shankar Musunuri, Chairman, Chief Executive Officer and Co-Founder of Ocugen will present at the BIO CEO & Investor Conference being held February 6-9, 2023, at the Marriott Marquis in New York City. Dr. Musunuri and members of Ocugen’s executive tea
- Motley Fool
2 Struggling Stocks to Buy Hand Over Fist in 2023 and 1 to Avoid Like the Plague
Teladoc Health (NYSE: TDOC) sank 74% last year -- and for one particular reason. The telemedicine giant reported two billion-dollar noncash goodwill impairment charges. Both were linked to the acquisition of chronic-care specialist Livongo.
- Motley Fool
3 of the Fastest-Growing Stocks on the Planet in 2023
It's why the Nasdaq Composite lost a third of its value last year. Despite this turmoil, some growth stocks are expected to deliver phenomenal sales growth in 2023 -- even as their share prices come under pressure. What follows are three of the fastest-growing stocks on the planet in 2023.
